PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
STAT3 |
|
200.000 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
STAT3 |
|
200.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
200.000 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
200.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
200.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
200.000 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
200.000 |
Evidence |
|
RNASE4 |
ANG, RNASE5: Angiogenin precursor |
C6 |
C6: Complement component C6 precursor |
200.000 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
200.000 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
200.000 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
200.000 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
200.000 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
200.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
199.000 |
Evidence |
|
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
199.000 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
198.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
198.000 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
SYK |
SYK: Tyrosine-protein kinase SYK |
198.000 |
Evidence |
|
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
196.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
BMX |
IPI00514142 |
196.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
196.000 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
196.000 |
Evidence |
|
RUNX3 |
IPI00218386 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
195.000 |
Evidence |
|
WASPIP |
IPI00552369 |
PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
194.000 |
Evidence |
|
SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
LSM2 |
LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 |
194.000 |
Evidence |
|